BNP Paribas Financial Markets’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
|
|||||
|
2025
Q1 | $876K | Sell |
|
|||||
|
2024
Q4 | $1.33M | Buy |
|
|||||
|
2024
Q3 | $453K | Sell |
|
|||||
|
2024
Q2 | $2.9M | Buy |
|
|||||
|
2024
Q1 | $601K | Buy |
|
|||||
|
2023
Q4 | $371K | Sell |
|
|||||
|
2023
Q3 | $343K | Buy |
|
|||||
|
2023
Q2 | $204K | Sell |
|
|||||
|
2023
Q1 | $170K | Buy |
|
|||||
|
2022
Q4 | $160K | Sell |
|
|||||
|
2022
Q3 | $176K | Sell |
|
|||||
|
2022
Q2 | $348K | Sell |
|
|||||
|
2022
Q1 | $567K | Sell |
|
|||||
|
2021
Q4 | $803K | Buy |
|
|||||
|
2021
Q3 | $329K | Buy |
|
|||||
|
2021
Q2 | $189K | Sell |
|
|||||
|
2021
Q1 | $309K | Sell |
|
|||||
|
2020
Q4 | $236K | Sell |
|
|||||
|
2020
Q3 | $209K | Sell |
|
|||||
|
2020
Q2 | $1.05M | Buy |
|
|||||
|
2020
Q1 | $240K | Buy |
|
|||||
|
2019
Q4 | $234K | Sell |
|
|||||
|
2019
Q3 | $146K | Buy |
|
|||||
|
2019
Q2 | $90K | Sell |
|
|||||
|
2019
Q1 | $289K | Buy |
|
|||||
|
2018
Q4 | $32K | Sell |
|
|||||
|
2018
Q3 | $119K | Buy |
|
|||||
|
2018
Q2 | $78.1K | Buy |
|